Liposome-Delivered Si(IV)-Naphthalocyanine for Tumor Treatment
Author Information
Author(s): V. Cuomo, G. Joril, B. Rihter, M.E. Kenney, M.A.J. Rodgers
Primary Institution: University of Padova, Bowling Green State University, Case Western Reserve University
Hypothesis
Can iso-BOSiNc, a liposome-delivered photosensitizer, effectively treat tumors through photodynamic therapy?
Conclusion
Iso-BOSiNc is a highly effective photosensitizer for photodynamic therapy of tumors, showing significant tumor necrosis.
Supporting Evidence
- Iso-BOSiNc is preferentially transported by serum lipoproteins, particularly LDL and HDL.
- Significant concentrations of iso-BOSiNc are accumulated in tumors while being minimally present in surrounding muscle.
- The extent of tumor necrosis increases with time after photodynamic therapy and is dependent on the irradiation dose-rate.
Takeaway
This study shows that a special drug can help kill tumor cells when light is shined on it, making it a good option for cancer treatment.
Methodology
The study involved injecting Balb/c mice with iso-BOSiNc and measuring its distribution and effectiveness in inducing tumor necrosis after photodynamic therapy.
Limitations
The pharmacokinetic behavior could not be followed beyond one week due to tumor necrosis.
Participant Demographics
Female Balb/c mice, 18-20 g body weight.
Want to read the original?
Access the complete publication on the publisher's website